Taxol And Taxotere Both Cleared For Routine Use After Bristol Appeal To U.K.
Executive Summary
Both Bristol-Myers Squibb's Taxol and Aventis' Taxotere have been recommended for routine use by U.K.' s National Institute for Clinical Excellence for advanced second-line breast cancer treatment, following a successful appeal by Bristol.